Steroids, SARMs, and peptides with T1D: what's documented
No hype, no lecture. What research and community reports say these compounds do to glucose, what nobody knows yet, the legal reality, and what to watch.
5 min read
Search any T1D community for these topics and you'll find the same pattern: someone asks, half the replies are lectures, the other half are guesses, and the thread dies without anyone citing actual evidence. This page is the missing middle: what's documented, what's community-reported, and what's genuinely unknown.
Anabolic steroids: the documented glucose story
This is the best-studied corner of the topic, and the findings are consistent. Anabolic steroids stimulate the liver to produce more glucose while simultaneously making muscle and fat tissue less responsive to insulin, likely through downregulation of insulin receptors. Net effect: glucose rises and insulin requirements climb.
The numbers are not subtle. One review of high-dose users found that 86 percent experienced at least one episode of hyperglycemia, and 41 percent averaged blood glucose above 140 mg/dL. At the extreme end, there's a published case report of a young bodybuilder using growth hormone, trenbolone, and testosterone who developed new-onset diabetes and presented to the hospital with a glucose of 1166 mg/dL. That's a person whose pancreas worked fine before.
For someone with T1D, the translation is straightforward: a compound that raises insulin resistance raises insulin needs, potentially by a lot, potentially unevenly across the day, and the change reverses on its own schedule when the compound clears. Every step of that is a moving target for glucose management, which is exactly why this belongs in a conversation with your endocrinologist and not in trial-and-error.
SARMs: glucose is the least of the documented problems
SARMs get marketed as the safer alternative, which makes the documented record worth reading closely. The FDA's consumer warning links them to heart attack, stroke, and liver damage. A systematic review of recreational use found impaired insulin sensitivity among reported adverse events, along with 15 documented cases of drug-induced liver injury. Recreational doses routinely exceed anything studied clinically, and there is no long-term safety data. None.
There's also a purity problem that exists before pharmacology even starts: analyses of black-market SARM products regularly find mislabeled ingredients, wrong quantities, or entirely different compounds. For someone whose daily safety depends on predictable insulin math, an unpredictable ingredient list is its own category of risk.
Growth hormone peptides: the clearest T1D-relevant signal
The compounds sold as "peptides" range from GH secretagogues like MK-677 (technically not a peptide, but marketed alongside them) to healing peptides like BPC-157. The glucose-relevant fact: growth hormone directly antagonizes insulin. Raise GH chronically and insulin resistance follows.
MK-677 has actual clinical numbers behind that: in trial data, five participants on MK-677 versus one on placebo developed impaired fasting glucose or diabetes-range values, and a two-month study in obese men found fasting glucose up and insulin up 26 percent. Even the bodybuilding community's own educators flag blood sugar as the MK-677 side effect people learn about the hard way, and they say it to audiences of millions.
The rest of the peptide catalog is mostly an evidence desert. BPC-157's human trials stopped without conclusions. For most compounds in this space, nobody can tell you the glucose effect because nobody has measured it.
What nobody knows
Honesty section. Nearly everything above was studied in people without diabetes. There are no controlled studies of these compounds in people with T1D. The community reports that exist are individual, unverified, and confounded by everything else in those people's routines. Whether effects hit harder or differently in a body with no endogenous insulin, how fast resistance shifts on and off, what it does to hypo risk when a compound clears: unstudied, unknown, unwritten. Anyone who claims certainty here, in either direction, is guessing.
The legal reality
Short version: testosterone and other anabolic steroids are Schedule III controlled substances in the US. Possessing them without a prescription is a federal crime. SARMs are not approved for human use in any form, are illegal to sell in supplements, and are prohibited in essentially all tested sport, as are the steroids and GH compounds. If you compete in anything with a drug-testing policy, this entire page is on the banned list.
If this is live for you
Not a plan, just the conversation that should happen:
For the appointment